| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |